Alzheimer's disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression

S Meftah, J Gan - Frontiers in Synaptic Neuroscience, 2023 - frontiersin.org
The synapse has consistently been considered a vulnerable and critical target within
Alzheimer's disease, and synapse loss is, to date, one of the main biological correlates of …

What electrophysiology tells us about Alzheimer's disease: a window into the synchronization and connectivity of brain neurons

C Babiloni, K Blinowska, L Bonanni, A Cichocki… - Neurobiology of …, 2020 - Elsevier
Electrophysiology provides a real-time readout of neural functions and network capability in
different brain states, on temporal (fractions of milliseconds) and spatial (micro, meso, and …

Early restoration of parvalbumin interneuron activity prevents memory loss and network hyperexcitability in a mouse model of Alzheimer's disease

S Hijazi, TS Heistek, P Scheltens, U Neumann… - Molecular …, 2020 - nature.com
Neuronal network dysfunction is increasingly recognized as an early symptom in
Alzheimer's disease (AD) and may provide new entry points for diagnosis and intervention …

[HTML][HTML] Reactive astrocytes: The nexus of pathological and clinical hallmarks of Alzheimer's disease

BR Price, LA Johnson, CM Norris - Ageing research reviews, 2021 - Elsevier
Astrocyte reactivity is a hallmark of neuroinflammation that arises with Alzheimer's disease
(AD) and nearly every other neurodegenerative condition. While astrocytes certainly …

A multiscale brain network model links Alzheimer's disease-mediated neuronal hyperactivity to large-scale oscillatory slowing

AM van Nifterick, AA Gouw, RE van Kesteren… - Alzheimer's research & …, 2022 - Springer
Background Neuronal hyperexcitability and inhibitory interneuron dysfunction are frequently
observed in preclinical animal models of Alzheimer's disease (AD). This study investigates …

Vagus nerve stimulation as a potential therapy in early Alzheimer's disease: A review

M Vargas-Caballero, H Warming, R Walker… - Frontiers in human …, 2022 - frontiersin.org
Cognitive dysfunction in Alzheimer's disease (AD) is caused by disturbances in neuronal
circuits of the brain underpinned by synapse loss, neuronal dysfunction and neuronal death …

Role of the extracellular matrix in Alzheimer's disease

Y Sun, S Xu, M Jiang, X Liu, L Yang, Z Bai… - Frontiers in Aging …, 2021 - frontiersin.org
Alzheimer's disease (AD) is a neurodegenerative disease with complex pathological
characteristics, whose etiology and pathogenesis are still unclear. Over the past few …

Limiting RyR2 open time prevents Alzheimer's disease-related neuronal hyperactivity and memory loss but not β-amyloid accumulation

J Yao, B Sun, A Institoris, X Zhan, W Guo, Z Song, Y Liu… - Cell reports, 2020 - cell.com
Neuronal hyperactivity is an early primary dysfunction in Alzheimer's disease (AD) in
humans and animal models, but effective neuronal hyperactivity-directed anti-AD …

Viscoelasticity of amyloid plaques in transgenic mouse brain studied by Brillouin microspectroscopy and correlative Raman analysis

S Mattana, S Caponi, F Tamagnini… - Journal of innovative …, 2017 - World Scientific
Amyloidopathy is one of the most prominent hallmarks of Alzheimer's disease (AD), the
leading cause of dementia worldwide, and is characterized by the accumulation of amyloid …

[HTML][HTML] Lamotrigine rescues neuronal alterations and prevents seizure-induced memory decline in an Alzheimer's disease mouse model

E Rizzello, D Pimpinella, A Pignataro, G Titta… - Neurobiology of …, 2023 - Elsevier
Epilepsy is a comorbidity associated with Alzheimer's disease (AD), often starting many
years earlier than memory decline. Investigating this association in the early pre …